Liliana E Pezzin1, Purushottam Laud, Tina W F Yen, Joan Neuner, Ann B Nattinger. 1. *Department of Medicine †Center for Patient Care and Outcomes Research ‡Division of Biostatistics, Institute for Health and Society §Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.
Abstract
OBJECTIVE: To reexamine the relationship of hospital and surgical volume to all-cause and breast cancer-specific mortality, taking into account the potential selection bias in patients treated at high-volume centers or by high-volume surgeons. DATA SOURCES: Elderly (65+) women with early-stage, incident breast cancer surgery in 2003. STUDY DESIGN: A population-based, prospective survey study. METHODS: Two-stage, instrumental variable regression models. PRINCIPAL FINDINGS: Women treated in high-volume hospitals were significantly less likely to die of any cause by 5 years after surgery, even after adjustments for self-selection and a number of other factors. The relationship was larger and more significant for breast cancer-specific mortality. Although the general pattern of better mortality outcomes held for moderately sized hospitals, the relationships were not statistically significant. In contrast, there was no relationship of surgeon volume with all-cause or breast cancer-specific mortality. CONCLUSIONS: Hospital volume, but not surgeon volume, is associated with better survival among women with breast cancer. The magnitude of the potential improvement was substantial and comparable with the benefit conferred by many systemic therapies. These findings highlight the importance of accounting for patient self-selection in volume-outcome analyses, and provide support for policy initiatives aimed at regionalizing breast cancer care in the United States.
OBJECTIVE: To reexamine the relationship of hospital and surgical volume to all-cause and breast cancer-specific mortality, taking into account the potential selection bias in patients treated at high-volume centers or by high-volume surgeons. DATA SOURCES: Elderly (65+) women with early-stage, incident breast cancer surgery in 2003. STUDY DESIGN: A population-based, prospective survey study. METHODS: Two-stage, instrumental variable regression models. PRINCIPAL FINDINGS:Women treated in high-volume hospitals were significantly less likely to die of any cause by 5 years after surgery, even after adjustments for self-selection and a number of other factors. The relationship was larger and more significant for breast cancer-specific mortality. Although the general pattern of better mortality outcomes held for moderately sized hospitals, the relationships were not statistically significant. In contrast, there was no relationship of surgeon volume with all-cause or breast cancer-specific mortality. CONCLUSIONS: Hospital volume, but not surgeon volume, is associated with better survival among women with breast cancer. The magnitude of the potential improvement was substantial and comparable with the benefit conferred by many systemic therapies. These findings highlight the importance of accounting for patient self-selection in volume-outcome analyses, and provide support for policy initiatives aimed at regionalizing breast cancer care in the United States.
Authors: Nicole Hébert-Croteau; Jacques Brisson; Jacques Lemaire; Jean Latreille; Raynald Pineault Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Mary Ann Gilligan; Joan Neuner; Xu Zhang; Rodney Sparapani; Purushottam W Laud; Ann B Nattinger Journal: Am J Public Health Date: 2007-01-31 Impact factor: 9.308
Authors: Bellal Joseph; John M Morton; Tina Hernandez-Boussard; Ilan Rubinfeld; Chadi Faraj; Vic Velanovich Journal: J Am Coll Surg Date: 2009-04 Impact factor: 6.113
Authors: G A Gooiker; W van Gijn; P N Post; C J H van de Velde; R A E M Tollenaar; M W J M Wouters Journal: Eur J Surg Oncol Date: 2010-09 Impact factor: 4.424
Authors: France Vrijens; Sabine Stordeur; Koen Beirens; Stephan Devriese; Elizabeth Van Eycken; Joan Vlayen Journal: Breast Date: 2011-12-26 Impact factor: 4.380
Authors: Amanda L Kong; Tina W F Yen; Liliana E Pezzin; Haiyan Miao; Rodney A Sparapani; Purushottam W Laud; Ann B Nattinger Journal: Ann Surg Oncol Date: 2011-08-23 Impact factor: 5.344
Authors: Ann Butler Nattinger; Liliana E Pezzin; Rodney A Sparapani; Joan M Neuner; Toni K King; Purushottam W Laud Journal: Am J Epidemiol Date: 2010-07-21 Impact factor: 4.897
Authors: Ann Butler Nattinger; Purushottam W Laud; Rodney A Sparapani; Xu Zhang; Joan M Neuner; Mary Ann Gilligan Journal: Arch Intern Med Date: 2007-10-08
Authors: Rachel A Greenup; Samilia Obeng-Gyasi; Samantha Thomas; K Houck; Whitney O Lane; Rachel C Blitzblau; Terry Hyslop; E Shelley Hwang Journal: Ann Surg Date: 2018-02 Impact factor: 12.969
Authors: Emma L Herbach; Bradley D McDowell; Elizabeth A Chrischilles; Benjamin J Miller Journal: Am J Clin Oncol Date: 2022-07-06 Impact factor: 2.787
Authors: Natalie J Del Vecchio; Natoshia M Askelson; Knute D Carter; Elizabeth Chrischilles; Charles F Lynch; Mary E Charlton Journal: Am J Surg Date: 2020-10-15 Impact factor: 2.565
Authors: Maryse C Cnossen; Thomas A van Essen; Iris E Ceyisakar; Suzanne Polinder; Teuntje M Andriessen; Joukje van der Naalt; Iain Haitsma; Janneke Horn; Gaby Franschman; Pieter E Vos; Wilco C Peul; David K Menon; Andrew Ir Maas; Ewout W Steyerberg; Hester F Lingsma Journal: Clin Epidemiol Date: 2018-07-18 Impact factor: 4.790